|
|
Volumn 2, Issue 6, 2000, Pages 547-553
|
|
Monoclonal antibody-based therapy for neuroblastoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOKINE;
MONOCLONAL ANTIBODY;
BONE MARROW PURGING;
BONE MARROW TRANSPLANTATION;
CHILD;
DISEASE FREE SURVIVAL;
GENETIC ENGINEERING;
HUMAN;
IMMUNOLOGY;
IMMUNOMAGNETIC SEPARATION;
METASTASIS;
NEUROBLASTOMA;
PROGNOSIS;
REVIEW;
ANTIBODIES, MONOCLONAL;
BONE MARROW PURGING;
BONE MARROW TRANSPLANTATION;
CHILD;
CYTOKINES;
DISEASE-FREE SURVIVAL;
GENETIC ENGINEERING;
HUMANS;
IMMUNOMAGNETIC SEPARATION;
NEOPLASM METASTASIS;
NEUROBLASTOMA;
PROGNOSIS;
|
|
EID: 0034326566
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-000-0109-6 Document Type: Review |
|
Times cited : (18)
|
|
References (55)
|
